Royal Bank of Canada »

Carmell Therapeutics Corp - US shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 67 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Carmell Therapeutics Corp - US

Vanguard Group
Carnegie Mellon University
Citadel Advisors
Hubbell Strickland Wealth Management
UBS Group
Wells Fargo & Company
Royal Bank of Canada
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Carmell Therapeutics Corp - US